Patients getting gender-affirming operations nearly tripled in recent years. States are limiting these surgeries for minors, though few have them.
Author: Ken Alltucker, USA TODAY
Esai and Biogen, Leqembi manufacturer, receive FDA approval for Alzheimer’s drug
Eisai and Biogen’s drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA’s full review.
Fourth of July fireworks come as some parts of US are ‘primed to burn’
Experts warn hot, dry conditions are ripe for wildfires ahead of Fourth of July celebrations. Some cities turn to drone light displays to curb risk.
Drugmaker Merck sues the Biden administration over Medicare’s drug price negotiations
Merck said the price negotiations are a ‘sham’ that compel drugmakers to accept lower prices, according to a lawsuit.
FDA seeks to ease cancer drug shortage with China-made imports
More than one dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin. U.S. eases import restrictions.
FDA seeks to ease cancer drug shortage with China-made imports
More than one dozen cancer drugs have been in shortage in recent months, including cisplatin and carboplatin. U.S. eases import restrictions.
FDA warns about herbal drug kratom, used for pain relief: What to know about side effects
The FDA recently seized a large shipment of kratom. Here’s what to know about the herbal drug and how it’s used to treat pain and anxiety.
Artificial intelligence helps researchers find new antibiotic to fight deadly superbug
Researchers report they used an AI algorithm to predict molecules that would neutralize the drug-resistant bacteria Acinetobacter baumannii.
Cease-fire in Sudan extended three days, Secretary of State Antony Blinken says: Live updates
The U.S. has deployed intelligence, surveillance and reconnaissance assets to aid people traveling by land from Khartoum to the Port of Sudan.
As states cut Medicaid, some fear they’ll mistakenly end coverage for millions of eligible people
States are resuming Medicaid eligibility checks that were paused during the COVID public health emergency.